Skip to main content
SpringerLink
Log in

Cimetidine and Other Histamine H2-Receptor Antagonists

  • Chapter
Drug Discovery and Development

Abstract

The treatment of peptic ulcer disease (both duodenal and gastric ulcers) and other acid-related diseases has been revolutionized by the discovery of the antagonist drugs that act at the histamine H2-receptor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Algieri, A. A., Luke, G. M., Standridge, R. T., Brown, M., Partyka, R. A., and Crenshaw, R. R. (1982) 1,2,5-Thiazole 1-oxide and 1,1-dioxide derivatives. A new class of potent histamine H2-receptor antagonists. J. Med. Chem. 25, 210–212.

    Google Scholar 

  • Ash, A. S. F. and Schild, H. O. (1966) Receptors mediating some actions of histamine. Br. J. Pharmac. Chemother. 27, 427–439.

    CAS  Google Scholar 

  • Betton, G. R. and Salmon, G. K. (1984) Pathology of the forestomach in rats treated for 1-year with a new histamine H2-receptor antagonist, SK&F 93479 trihydrochloride. Scand. J. Gastroenterol. 19 (suppl. 101), 103–108.

    CAS  Google Scholar 

  • Black, J. W., Duncan, W. A. M., Durant, G. J., Ganellin, C. R., and Parsons, M. E. (1972) Definition and antagonism of histamine H2-receptors. Nature 236, 385–390.

    Article  PubMed  CAS  Google Scholar 

  • Black, J. W., Duncan. W. A. M., Emmett, J. C., Ganellin, C. R., Hesselbo, T., Parsons, M. E., and Wyllie, J. H. (1973) Metiamide an orally active histamine H2-receptor antagonist. Agents Actions 3, 133–137.

    Article  PubMed  CAS  Google Scholar 

  • Black, J. W., Durant, G. J., Emmett, J. C., and Ganellin, C. R. (1974) Sulphur-methylene isosterism in the development of metiamide, a new histamine H2-receptor antagonist. Nature 248, 65–67.

    Article  PubMed  CAS  Google Scholar 

  • Blakemore, R. C., Brown, T. H., Durant, G. J., Emmett, J. C., Ganellin, C. R., Parsons, M. E., and Rasmussen, A. C. (1980) SK&F 92994: A new histamine H2-receptor antagonist. Br. J. Pharmacol. 70, 105 P.

    Google Scholar 

  • Blakemore, R. C., Brown, T. H., Durant, G. J., Ganellin, C. R., Parsons, M. E., Rasmussen, A. C., and Rawlings, D. A. (1981) SK&F 93479: A potent and long-acting histamine H2-receptor antagonist. Br. J. Pharmacol. 74, 200 P.

    Google Scholar 

  • Blakemore, R. C., Brown, T. H., Cooper, D. G., Durant, G. J., Ganellin, C. R., Ife, R. J., Parsons, M. E., Rasmussen, A. C., and Sach, G. S. (1983) SK&F 93319: A specific antagonist of histamine at H1- and H2 -receptors. Br. J. Pharmacol. 80, 437 P.

    Google Scholar 

  • Bokelman, D. L. (1984) Famotidine: A potent histamine H2-receptor antagonist. Summary of preclinical safety. Ital. J. Gastroenterol. 16, 176–177.

    Google Scholar 

  • Bradshaw, J., Brittain, R. T., Clitherow, J. W., Daly, M. J., Jack, D., Price, B. J., and Stables, R. (1979) AH 19065: A new potent, selective histamine H2-receptor antagonist. Br. J. Pharmacol. 66, 464 P.

    Google Scholar 

  • Brimblecombe, R. W. and Duncan, W. A.M. (1977) The Relevance to Man of Preclinical Data for Cimetidine, in Cimetidine: Proceedings of the Second International Symposium on Histamine H 2 -Receptor Antagonists ( Burland, W. L. and Simkins, M. A., eds.) Excerpta Medica, Oxford/Amsterdam.

    Google Scholar 

  • Brimblecombe, R. W., Duncan, W. A. M., and Walker, T. F. (1973) Toxicology of Metiamide, in Proceedings of International Symposium on Histamine H 2 -Receptor Antagonists London 1973 ( Wood, C. J. and Simpkins, S. A., eds.) Welwyn Garden City, Hertfordshire.

    Google Scholar 

  • Brimblecombe, R. W., Duncan, W. A. M., and Parsons, M. E. (1974) Metiamide, a histamine H2-receptor antagonist. Pharmacology and toxicology. S. African Med. J. 48, 2253–2255.

    CAS  Google Scholar 

  • Brimblecombe, R. W., Duncan, W. A. M., Durant, G. J., Emmett, J. C., Ganellin, C. R., and Parsons, M. E. (1975) Cimetidine—a non-thiourea H2-receptor antagonist. J. Int. Med. Res. 3, 86–92.

    CAS  Google Scholar 

  • Brimblecombe, R. W., Leslie, G. B., and Walker, T. F. (1985) Toxicology of cimetidine. Human Toxicol. 4, 13–25.

    Article  CAS  Google Scholar 

  • Brittain, R. T. and Daly, M. J. (1981) A review of the animal pharmacology of ranitidine—a new, selective histamine H2-antagonist. Scand. J. Gastroenterol. 16, (suppl. 69), 1–9.

    CAS  Google Scholar 

  • Brittain, R. T., Daly, M. J., Humphray, J. M., and Stables, R. (1982) AH 22216, a new long acting histamine H2-receptor antagonist. Br. J. Pharmacol. 76, 195 P.

    Google Scholar 

  • Burland, W. L. and Mills, J. G. (1982) The Pathophysiological Role of Histamine and Potential Therapeutic Uses of H1- and H2-Antihistamines, in Pharmacology of Histamine Receptors ( Ganellin, C. R. and Parsons, M. E., eds.) Wright, Bristol, London, Boston.

    Google Scholar 

  • Burland, W. L., Sharpe, P. C., Colin-Jones, D. G., Turnball, P. R. G., and Bowskill, P. (1975) Reversal of metiamide-induced agranulocytosis during treatment with cimetidine. Lancet ii, 1085.

    Article  Google Scholar 

  • Burland, W. L., Brunet, P. L., Hunt, R. H., Melvin, M. A., Mills, J. G., Vincent, D., and Milton-Thompson, G. J. (1980) Comparison of the effects on 24 h intragastric acidity of SK&F 92994 and two dose regimens of cimetidine (abstract). Hepatogastroenterol. (suppl.) 259 X I Int. Cong. Gastroenterol., Hamburg.

    Google Scholar 

  • Buyniski, J. P., Cavanagh, R. L., Pircio, A. W., Algieri, A. A., and Crenshaw, R. R. (1984) Structure-Activity Relationships Among Newer Histamine H2-receptor Antagonists, in Highlights in Receptor Chemistry ( Melchiorre, C. and Giannella, M., eds.) Elsevier, Amsterdam, New York, Oxford.

    Google Scholar 

  • Capurso, L., Dal Monte, P. R., Mazzeo, F., Menardo, G., Morettini, A., Saggioro, A., and Tafner, G. (1984) Comparison of cimetidine 800 mg once daily and 400 mg twice daily in acute duodenal ulceration. Br. Med. J. 289, 1418–1420.

    Article  CAS  Google Scholar 

  • Cavanagh, R. L., Usakewicz, J. J., and Buyniski, J. P. (1980) Comparative activities of three new histamine H2-receptor antagonists—BL-5641, ranitidine and ICI-125,211. Fed. Proc. 39, 426.

    Google Scholar 

  • Cavanagh, R. L., Usakewicz, J. J., and Buyniski, J. P. (1981) BL-6341A: A new selective histamine H2-receptor antagonist with more prolonged gastric antisecretory activity than cimetidine and ranitidine (abstract). Fed. Proc. 40, 693.

    Google Scholar 

  • Cavanagh, R. L., Usakewicz, J. J., and Buyniski, J. P. (1983) A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist with those of cimetidine, ranitidine and tiotidine. J. Pharmacol. Exp. Ther. 224, 171–179.

    PubMed  CAS  Google Scholar 

  • Code, C. F. (1974) New antagonists excite an old histamine prospector. N. Eng. J. Med. 290, 738–740.

    Article  CAS  Google Scholar 

  • Colin-Jones, D. G., Langman, M. J. S., Lawson, D. H., and Vessey, M. P. (1982) Cimetidine and gastric cancer: Preliminary report from postmarketing surveillance study. Br. Med. J. 285, 1311–1313.

    Article  CAS  Google Scholar 

  • Colin-Jones, D. G., Langman, M. J. S., Lawson, D. IL, and Vessey, M. P. (1983) Postmarketing surveillance of the safety of cimetidine: 12 month mortality report. Br. Med. J. 286, 1713–1716.

    Article  CAS  Google Scholar 

  • Crean, G. P., Morson, B. C., Leslie, G. B., and Roe, F. J. C. (1981a) Cimetidine further evidence of noncarcinogenicity in dogs. N. Engl. J. Med. 304, 672.

    PubMed  CAS  Google Scholar 

  • Crean, G. P., Leslie, G. B., Walker, T. F., Whitehead, S. M., and Roe, F. J. C. (1981b) Safety evaluation of cimetidine: 54 month interim report on long-term study in dogs. J. Appl. Toxicol. 1, 159–164.

    Article  PubMed  CAS  Google Scholar 

  • Delattre, M. and Dickson, B. (1984) Cimetidine once daily. Lancet i, 625.

    Article  Google Scholar 

  • Donetti, A., Cereda, E., Bellora, E., Gallazzi, A., Bazzano, c., Vanoni, P., Del Soldato, P., Micheletti, R., Pagani, F., and Giachetti, A. (1984) (Imidazolylphenyl) formamidines. A structurally novel class of potent histamine H2-receptor antagonist. J. Med. Chem. 27, 380–386.

    Google Scholar 

  • Dragstedt, L. R. and Owens, F. M. (1943) Supradiaphragmatic section of the vagus nerves in treatment of duodenal ulcer. Proc. Soc. Exp. Biol. 53, 152–154.

    Google Scholar 

  • Drasaar, B. S., Shiner, M., and McLeod, G. M. (1969) The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology 56, 71–79.

    Google Scholar 

  • Durant, G. J., Parsons, M. E., and Black, J. W. (1975) Potential histamine H2-receptor antagonists, 2.Nα-guanylhistamine. J. Med. Chem. 18, 830–833.

    Article  PubMed  CAS  Google Scholar 

  • Durant, G. J., Emmett, J. C., Ganellin, C. R., and Prain, H. D. (1976) Heterocyclic substituted-1, 1-diamino-ethylene derivatives, methods for their preparation and compositions containing them. Smith Kline and French Laboratories, British Patent 1 421 792.

    Google Scholar 

  • Durant, G. J., Emmett, J. C., Ganellin, C. R., Miles, P. D., Prain, H. D., Parsons, M. E., and White, G. R. (1977) Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist cimetidine. J. Med. Chem. 20, 901–906.

    Article  PubMed  CAS  Google Scholar 

  • Durant, G. J., Brown, T. H., Emmett, J. C., Ganellin, C. R., Prain, H. D., and Young, R. C. (1982) Some Structure—Activity Considerations in H2-receptor Antagonists, in The Chemical Regulation of Biological Systems (Creighton, A. M. and Turner, S., eds.) special publication no. 42, The Royal Society of Chemistry, London.

    Google Scholar 

  • Elder, J. B., Ganculi, P. C., and Gillespie, I. E. (1979) Cimetidine and gastric cancer. Lancet i, 1005–1006.

    Article  Google Scholar 

  • Flind, A. C., Rowley-Jones, D., and Backhouse, J. N. (1980) The Safety of Cimetidine: A Continuing Assessment, in Proceedings of European Symposium Italy, 1979, H2-receptor Antagonists in Peptic Ulcer disease and Progress in Histamine Research, ( Torsoli, A., Lucchelli, P. E., Brimblecombe, R. W., eds.) Excerpta Medica, Oxford, Amsterdam.

    Google Scholar 

  • Forrest, J. A. H., Shearman, D. J. C, Spence, R., and Celestin, L. R. (1975) Neutropenia associated with metiamide. Lancet i, 392–393.

    Article  Google Scholar 

  • Ganellin, C. R. (1978) Chemistry and Structure—Activity Relationships of H2-receptor Antagonists, in Handbook of Experimental Pharmacology XVIII /2 ( Rocha e Silva, M., ed.) Springer Verlag, Berlin, Heidelberg, New York.

    Google Scholar 

  • Ganellin, R. (1981) Medicinal chemistry and dynamic structure—activity analysis in the discovery of drugs acting at histamine H2-receptors. J. Med. Chem. 24, 913–920.

    Article  PubMed  CAS  Google Scholar 

  • Ganellin, C. R., Durant, G. J., and Emmett,J. C. (1976) Some chemical aspects of histamine H2-receptor antagonists. Fed. Proc. 35, 1924–1930.

    PubMed  CAS  Google Scholar 

  • Gilman, D. J., Jones, D. F., Oldham, K., Wardleworth, J. M., and Yellin, T. O. (1982) 2-Guanidinothiazoles as H2-receptor Antagonists, in The Chemical Regulation of Biological Systems (Creighton, A. M. and Turner, S., eds.) Special Publication No. 42, The Royal Society of Chemistry, London.

    Google Scholar 

  • Gledhill, T., Howard O. M., Buck, M., Paul, A., and Hunt, R. H. (1983) Single nocturnal dose of an H2-receptor antagonist for the treatment of duodenal ulcer. Gut 24, 904–908.

    Article  PubMed  CAS  Google Scholar 

  • Habs, M., Schmahl, D., Eisenbrand, G., and Preussmann, R. (1982) Carcinogenesis Studies with N–Nitrosocimetidine. 2. Oral Administration to Sprague-Dawley Rats, in Nitrosamines and Human Cancer (Banbury report 12) ( Magee, P. N., ed.) Cold Spring Harbor Laboratories, New York.

    Google Scholar 

  • Hardie, J., Piatt, R., Hutton, J., Warren, P., Lee, S. A., Harris, G. D., and Davies, E. P. (1984) Polymorphs (Imperial Chemical Industries pic) European Patent 115, 114.

    Google Scholar 

  • Harvey, C. A. and Owen, D. A. A. (1984) Cardiovascular studies with SK&F 93319, An antagonist of histamine at both H1- and H2-receptors. Br. J. Pharmacol. 83, 427–432.

    PubMed  CAS  Google Scholar 

  • Helman, C. A. and Tim, L. O. (1983) Pharmacology and clinical efficacy of ranitidine, a new H2-receptors antagonist. Pharmacother. 3, 185–192.

    CAS  Google Scholar 

  • Humphray, J. M., Daly, M. J., and Stables, R. (1982) Inhibition of gastric acid secretion by AH 22216, a new long-acting histamine H2-receptor antagonist (abstract). Gut 23, A899.

    Google Scholar 

  • Humphries, T. J., Myerson, R. M., Gifford, L. M., Aeugle, M. E., Josie, M. E., Wood, S. L., and Tannenbaum, P. J. (1984) A unique postmarket outpatient surveillance program of cimetidine: Report on Phase II and Final Summary. Am. J. Gastroent. 79, 593–596.

    PubMed  CAS  Google Scholar 

  • Johnson, L. R. (1971) Control of gastric secretion: No room for histamine? Gastroenterology 61, 106–118.

    PubMed  CAS  Google Scholar 

  • Kerr, G. D. (1981) Cimetidine: Twice Daily Administration in Duodenal Ulcer—Results of a UK and Ireland Multicentre Study, in Cimetidine in the 80’s ( Baron, J. H., ed.) Churchill Livingstone, Edinburgh.

    Google Scholar 

  • Lacerte, M., Rousseau, B., Parent, J. P., Pare, P., Levesque, D., and Falutz, S. (1984) Single daily dose of cimetidine for the treatment of symptomatic duodenal ul cer: Results of a comparative two-centre trial. Curr. Ther. Res. 35, 777–782.

    Google Scholar 

  • Larsson, L., Rehfeld, S., Stockbrugger, R., Blohme, G., Schoon, I. M., Lundqvist, G., Kindblom, L. G., Save-Soderberg, J., Grimelius, L., and Olbe, L. (1978) Mixed endocrine gastric tumors associated with hypergastrinemia of antral origin. Am. J. Pathol. 93, 53–68.

    PubMed  CAS  Google Scholar 

  • Leslie, G. B. and Walker, T. F. (1977) A Toxicological Profile of Cimetidine, in Cimetidine: Proceedings of the Second International Symposium on Histamine H 2 -Receptor Antagonists ( Burland, W. L. and Simkins, M. A., ed.) Excerpta Medica, Oxford, Amsterdam.

    Google Scholar 

  • Leslie, G. B., Noakes, D. N., Pollit, F. D., Roe, F. J. C, and Walker, T. F. (1981) A two-year study with cimetidine in the rat: Assessment for chronic toxicity and carcinogenicity. Tox. Appl. Pharmacol. 61, 19–137.

    Article  Google Scholar 

  • Lijinsky, W. (1982) Carcinogenesis Studies with Nitrosocimetidine, in Nitrosamines and Human Cancer (Banbury Report 12) ( Magee, P. N., ed.) Cold Spring Harbor Laboratories, New York.

    Google Scholar 

  • Lin, T. M., Evans, D. C., Warrick, M. W., Pioch, R. P., and Ruffolo, R. R. (1983) Nizatidine, a new specific H2-receptor antagonist. Gastroenterology 84, 1231.

    Google Scholar 

  • Loew, E. R. (1947) Pharmacology of antihistamine compounds. Physiological Rev. 27. 542–573.

    CAS  Google Scholar 

  • Lumma, W. C., Anderson, P. S., Baldwin, J. J., Bolhofer, W. A., Hakecker, C. N., Hirshfield, J. M., Pietruszkiewicz, A. M., Randall, W. C., Torchiana, M. L., Britcher, S. F., Clineschmidt, B. V., Denny, G. H., Hirschmann, R., Hoffman, J. M., Phillips, B. T., and Streeter, K. B. (1982) Inhibitors of gastric acid secretion: 3,4-diamino-l,2,5,-thiadiazole 1-oxides and 1,1-dioxides as urea equivalents in a series of histamine H2-receptor antagonists. J. Med. Chem. 25, 207–210.

    Article  PubMed  CAS  Google Scholar 

  • Mahachai, V., Thomson, A. B. R., Grace, M., Cook, D., and Symes, A. (1982) Comparison of two cimetidine regimes on 24-hour intragastric acidity in patients with duodenal ulcer disease (abstract). Gastroenterology 82 (5), 122.

    Google Scholar 

  • Nagata, T., Nagata, T., Hamabata, M., Sato, M., Murakiami, U., Enomoto, M., and Tamura, J. (1983) Oral toxicity studies of ranitidine hydrochloride in beagles. J. Toxicol. Sci. 8 (suppl. 1), 51–83.

    PubMed  CAS  Google Scholar 

  • Nielsen, S. T., Dove, P., Pal umbo, G., Sandor, A., Buonato, C., Schiehser, G., Santilli, A., and Strike, D. (1984) Two H2-receptor antagonists as inhibitors of gastric acid secretion (abstract), Fed. Proc. 43, 1074.

    Google Scholar 

  • Pounder, R. E., Williams, J. G., Hunt, R. H., Vincent, S. H., Milton-Thompson, G. J., and Misiewicz, J. J. (1977) The Effects of Oral cimetidine on Food-Stimulated Gastric Acid Secretion and 24-Hour Intragastric Acidity, in Cimetidine: Proceedings of the Second International Symposium on Histamine H 2 -Receptor Antagonists ( Burland, W. L. and Simkins, M. A., eds.) Excerpta Medica, Oxford, Amsterdam.

    Google Scholar 

  • Poynter, D., Pick, C. R., Harcourt, R. A., Sutherland, M. F., Spurting, N. W., Ainse, G., Cook, J., and Gatehouse, D. (1982) Evaluation of Ranitidine Safety, in The Clinical Use of Ranitidine, Second International Symposium on Ranitidine ( Misiewicz, J. J. and Wormsley, K. G., eds.) Med. Publ. Foundation.

    Google Scholar 

  • Price, B. J. and Daly, M. J. (1983) Ranitidine and Other H2-receptor Antagonists—Recent Developments, in Progress in Medical Chemistry (Ellis, G. P. and West, G. B., eds.) vol. 20. Elsevier, New York.

    Google Scholar 

  • Rendic, S., Sunjic, V., Toso, R., and Kajfez, F. (1979) Interaction of cimetidine with liver microsomes. Xenobiotica 9, 555–564.

    Article  PubMed  CAS  Google Scholar 

  • Rendic, S., Alebic-Kolbah, T., and Kajfez, F. (1982) Interaction of ranitidine with liver microsomes. Xenobiotica 12, 9–17.

    Article  PubMed  CAS  Google Scholar 

  • Rowley-Jones, D. and Flind, A. C. (1981) Continuing Evaluation of the Safety of Cimetidine, in Cimetidine in the 80’s. ( Baron, J. H., ed.) Churchill Livingstone, Edinburgh.

    Google Scholar 

  • Shibata, T. (1984) Mannich-phenoxy reversed acetyloxyacetamide (TZU-0460) (abstract 29N 1-2S). Communication to 104th Ann. Meetg. Japan Pharmaceutical Soc., Sendai.

    Google Scholar 

  • Sivelle, P. C., Underwood, A. H., and Jelly, J. A. (1982) The effects of histamine H2-receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro. Biochem. Pharmacol. 31, 677–684.

    Article  CAS  Google Scholar 

  • Stables, R. and Humphray, J. M. (1983) Antisecretory activity of loxtidine, a long acting H2-receptor blocking drug. Abstr. 012, 12th Meeting European Histamine Research Society, Brighton.

    Google Scholar 

  • Streett, C. S., Cimprich, R. E., and Robertson, J. L. (1984) Pathologic findings in the stomach of rats treated with the H2-receptor antagonist in tiotidine. Scand. J. Gastroenterol. 19 (Suppl. 101), 109–117.

    CAS  Google Scholar 

  • Sugimura, T., Nagao, M., and Okada, Y. (1966) Carcinogenic action of N-methyI-N’-nitro-N-nitrosoguanidine. Nature 210, 962–963.

    Article  PubMed  CAS  Google Scholar 

  • Suzuki, H. and Shiobara, Y. (1983) Acute toxicity of famotidine (YM-11170) in mice and rats. Oyo Yakuri 26, 147–150.

    CAS  Google Scholar 

  • Takagi, T., Takeda, M., and Maeno, H. (1982) Effect of a new potent H2-blocker, 3-[[[2[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gstric secretion induced by histamine and food in conscious dogs. Arch. Int. Pharmacodyn. 256, 49–58.

    PubMed  CAS  Google Scholar 

  • Takeda, M., Takagi, T., Yashima, Y., and Maeno, H. (1982) Effect of a new potent H2-blocker, 3-(((2[(diaminomethylene)amino]-4-thiazolyl] methyl]thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion, ulcer formation and weight of male accessory sex organs in rats. Arzneim. Forsch. 32, 734–737.

    CAS  Google Scholar 

  • Takeuchi, M., Kaga, M., Kiguchi, M., Twata, M., Yamaguchi, M., and Shimpo, K. (1983) Chronic toxicity study of ranitidine hydrochloride orally administered in rats. J. Toxicol. Sci. 8. (suppl. I), 25–49.

    PubMed  CAS  Google Scholar 

  • Tamura, J., Sato, N., Ezaki, H., Miyamoto, H., Oda, S., Hirsi, K., and Tokado, H. (1983a) Rabbits and subacute oral toxicity of ranitidine in rats. J. Toxicol. Sci. 8 (suppl. I), 1–24.

    PubMed  CAS  Google Scholar 

  • Tamura, J., Sato, N., Ezaki, H., and Yokoyama, S. (1983b) Teratological study on ranitidine hydrochloride in rabbits. J. Toxicol. Sci. 8 (suppl. I), 141–150.

    PubMed  CAS  Google Scholar 

  • Tarutani, M., Sakuma, H., Shiratsuchi, K., and Mieda, M. (1985a) Histamine H2-receptor antagonistic action of N-{3-[3-(1-Piperidinylmethyl) phenoxy]propyl}acetoxyacetamide hydrochloride (TZU-0460). Arzneim. Forsch. 35, 703–706.

    CAS  Google Scholar 

  • Tarutani, M., Sakuma, H.; Shiratsuchi, K., and Mieda, M. (1985b) Effects of N-|3-[3-(1-Piperidinylmethyl)phenoxy]propyl}-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist on gastric acid secretion and ulcer formation. Arzneim. Forsch. 35. 844–848.

    CAS  Google Scholar 

  • Torchiana, M. L., Pendleton, R. G., Cook, P. G., Hanson, C. A., and Clineschmidt, B. V. (1983) Apparent irreversible H2-receptor blocking and prolonged gastric antisecretory activities of 3-N[3-(1-piperidinomethyl)phenoxy]propyl]amino4-amino-l,2,5-thiadiazole-1-oxide (L-643,441). J. Pharmacol. Exp. Ther. 224, 514–519.

    PubMed  CAS  Google Scholar 

  • Tsuritani, M., Matsukawa, H., Aoki, H., and Seya, M. (1984) Inhibitory effects of 2-N-[3-[3-(1-piperidinomethyl)phenoxy]propyl]amino-5-amino-1,3,4-thiadiazole (TAS). Abstract 0-92, 57th Annual Meeting of Japanese Pharmacological Soc., Kyoto.

    Google Scholar 

  • Walker, T. F., Whitehead, S. M., Leslie, G. B., Crean, G. P., and Roe, F. J. C. (1987) Safety evaluation of cimetidine: Report at the termination of a 71/2 year study in dogs. Human Toxicol. 6, 159–164.

    Article  CAS  Google Scholar 

  • Wilson, J. A., Johnston, D. A., Pension, J., and Wormsley, K. G. (1986) Inhibition of human gastric secretion by ICI 162,846—a new histamine H2-receptor antagonist. B r. J. Clin. Pharmacol. 21, 685–689.

    CAS  Google Scholar 

  • Wormsley, K. G. (1984) Assessing the safety of drugs for the long-term treatment of peptic ulcers. Gut 25, 1416–1423.

    Article  PubMed  CAS  Google Scholar 

  • Wyllie, J. H., Hesselbo, T., and Black, J. W. (1972) Effects in man of histamine H2-receptor blockade by burimamide. Lancet ii, 1117–1120.

    Article  Google Scholar 

  • Yellin, T. O. and Gilman, D. J. (1982) Guanidine derivatives ICI Americas, European Patent 60, 094.

    Google Scholar 

  • Yellin, T. O., Buck, S. H., Gilman, D. J., Jones, D. F., and Wardleworth, J. M. (1979) ICI 125,211: A new gastric antisecretory agent acting on histamine H2-receptor. Life Sci. 25, 2001–2009.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Roger W. Brimblecombe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Robin Ganellin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Drug Discovery Administration, Pharmaceuticals Division, Ciba-Geigy Corporation, Summit, New Jersey, USA

    Michael Williams

  2. Biomedical Research Department, Stuart Pharmaceuticals, ICI Americas Inc., Wilmington, Delaware, USA

    Jeffrey B. Malick

Rights and permissions

Reprints and permissions

Copyright information

© 1987 The Humana Press Inc.

About this chapter

Cite this chapter

Brimblecombe, R.W., Ganellin, C.R. (1987). Cimetidine and Other Histamine H2-Receptor Antagonists. In: Williams, M., Malick, J.B. (eds) Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-4612-4828-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4828-6_13

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-4612-9180-0

  • Online ISBN: 978-1-4612-4828-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation